多学科风湿科/皮肤科诊所中银屑病和银屑病关节炎的管理
Management of Psoriasis and Psoriatic Arthritis in a Multidisciplinary Rheumatology/Dermatology Clinic.
作者信息
Cunha Joanne Szczygiel, Qureshi Abrar A, Reginato Anthony M
机构信息
is an assistant professor of medicine and an attending physician in the Division of Rheumatology, is the chief of dermatology, and is the rheumatology program director as well as director of rheumatology research and musculoskeletal ultrasound, all at the Warren Alpert Medical School of Brown University. Dr. Cunha and Dr. Qureshi are attending physicians and Dr. Reginato is acting chief of rheumatology, all at the Providence VA Medical Center.
出版信息
Fed Pract. 2015 Dec;32(Suppl 12):14S-20S.
Abstract
Early diagnosis, use of newly developed targeted therapies, and a multispecialty approach are essential for the treatment of patients with psoriasis and psoriatic arthritis.
摘要
早期诊断、使用新开发的靶向疗法以及多专科方法对于银屑病和银屑病关节炎患者的治疗至关重要。
相似文献
1
Management of Psoriasis and Psoriatic Arthritis in a Multidisciplinary Rheumatology/Dermatology Clinic.多学科风湿科/皮肤科诊所中银屑病和银屑病关节炎的管理
Fed Pract. 2015 Dec;32(Suppl 12):14S-20S.
2
Multidisciplinary dermatology-rheumatology management for patients with moderate-to-severe psoriasis and psoriatic arthritis: a systematic review.中重度银屑病和银屑病关节炎患者的多学科皮肤科-风湿病管理：一项系统评价
Rheumatol Int. 2016 Feb;36(2):221-9. doi: 10.1007/s00296-015-3377-z. Epub 2015 Oct 5.
3
Early Recognition and Treatment Heralds Optimal Outcomes: the Benefits of Combined Rheumatology-Dermatology Clinics and Integrative Care of Psoriasis and Psoriatic Arthritis Patients.早期识别和治疗预示着最佳结果：风湿免疫科-皮肤科联合门诊和银屑病及银屑病关节炎患者综合照护的优势。
Curr Rheumatol Rep. 2017 Nov 20;20(1):1. doi: 10.1007/s11926-017-0706-0.
4
Bridging the Gaps in the Care of Psoriasis and Psoriatic Arthritis: the Role of Combined Clinics.弥合银屑病和银屑病关节炎护理中的差距：联合诊所的作用。
Curr Rheumatol Rep. 2018 Oct 26;20(12):76. doi: 10.1007/s11926-018-0785-6.
5
A multidisciplinary approach in psoriatic disease: the different models of dermatology-rheumatology collaborations in Portugal.多学科方法治疗银屑病：葡萄牙皮肤科-风湿病学合作的不同模式。
Acta Reumatol Port. 2021 Oct-Dec;46(4):333-341.
6
Multidisciplinary psoriasis and psoriatic arthritis unit: report of 4 years' experience.多学科银屑病和银屑病关节炎诊疗单元：4年经验报告
Actas Dermosifiliogr. 2014 May;105(4):371-7. doi: 10.1016/j.ad.2013.10.009. Epub 2013 Dec 18.
7
A report of 4 years of experience of a multidisciplinary unit of psoriasis and psoriatic arthritis.一份关于银屑病和银屑病关节炎多学科诊疗单元4年经验的报告。
Reumatol Clin. 2014 May-Jun;10(3):141-6. doi: 10.1016/j.reuma.2014.01.004. Epub 2014 Mar 20.
8
Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) Survey: Benefits and Challenges of Combined Rheumatology-dermatology Clinics.银屑病与银屑病关节炎诊所多中心推进网络联盟（PPACMAN）调查：风湿科-皮肤科联合诊所的益处与挑战
J Rheumatol. 2017 May;44(5):693-694. doi: 10.3899/jrheum.170148.
9
Management of psoriasis and psoriatic arthritis in a combined dermatology and rheumatology clinic.皮肤科和风湿科联合诊所中银屑病和银屑病关节炎的管理。
Arch Dermatol Res. 2012 Jan;304(1):7-13. doi: 10.1007/s00403-011-1172-6.
10
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic.多学科管理银屑病关节炎患者的临床结局和可行性：皮肤科-风湿病诊所的两年临床经验。
Clin Rheumatol. 2018 Oct;37(10):2741-2749. doi: 10.1007/s10067-018-4238-4. Epub 2018 Jul 29.
引用本文的文献
1
Practical and Relevant Guidelines for the Management of Psoriasis: An Inference-Based Methodology.银屑病管理实用且相关指南：基于推理的方法
Dermatol Ther (Heidelb). 2022 Jan;12(1):253-265. doi: 10.1007/s13555-021-00642-5. Epub 2021 Dec 22.
2
Real-World Treatment Patterns and Healthcare Costs in Patients with Psoriatic Arthritis Treated with Ixekizumab: A Retrospective Study.使用司库奇尤单抗治疗的银屑病关节炎患者的真实世界治疗模式和医疗费用：一项回顾性研究。
ACR Open Rheumatol. 2021 Dec;3(12):879-887. doi: 10.1002/acr2.11347. Epub 2021 Sep 22.
本文引用的文献
1
Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors.托法替布可调节银屑病关节炎中的滑膜炎症，抑制信号转导和转录激活因子（STAT）的激活以及负反馈抑制剂的诱导。
Ann Rheum Dis. 2016 Jan;75(1):311-5. doi: 10.1136/annrheumdis-2014-207201. Epub 2015 Sep 9.
2
Pharmacologic treatment of psoriatic arthritis and axial spondyloarthritis with traditional biologic and non-biologic DMARDs.传统生物制剂和非生物 DMARDs 治疗银屑病关节炎和脊柱关节炎的药物治疗。
Best Pract Res Clin Rheumatol. 2014 Oct;28(5):793-806. doi: 10.1016/j.berh.2014.10.011. Epub 2014 Nov 22.
3
Comprehensive treatment of psoriatic arthritis: managing comorbidities and extraarticular manifestations.银屑病关节炎的综合治疗：合并症及关节外表现的管理
J Rheumatol. 2014 Nov;41(11):2315-22. doi: 10.3899/jrheum.140882.
4
Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review.银屑病关节炎外周关节病的药物治疗：一项系统评价。
J Rheumatol. 2014 Nov;41(11):2277-85. doi: 10.3899/jrheum.140876.
5
Systematic review of treatments for psoriatic arthritis: 2014 update for the GRAPPA.银屑病关节炎治疗的系统评价：2014年GRAPPA更新版
J Rheumatol. 2014 Nov;41(11):2273-6. doi: 10.3899/jrheum.140875.
6
Tumour necrosis factor inhibitor monotherapy vs combination with MTX in the treatment of PsA: a systematic review of the literature.肿瘤坏死因子抑制剂单药治疗与联合甲氨蝶呤治疗银屑病关节炎的疗效比较：文献系统评价
Rheumatology (Oxford). 2015 May;54(5):915-26. doi: 10.1093/rheumatology/keu415. Epub 2014 Oct 27.
7
Current treatment of psoriatic arthritis: update based on a systematic literature review to establish French Society for Rheumatology (SFR) recommendations for managing spondyloarthritis.银屑病关节炎的当前治疗：基于系统文献综述的更新，以制定法国风湿病学会（SFR）关于脊柱关节炎管理的建议。
Joint Bone Spine. 2015 Mar;82(2):80-5. doi: 10.1016/j.jbspin.2014.05.003. Epub 2014 Jul 2.
8
Development of criteria to distinguish inflammatory from noninflammatory arthritis, enthesitis, dactylitis, and spondylitis: a report from the GRAPPA 2013 Annual Meeting.区分炎性与非炎性关节炎、附着点炎、指（趾）炎和脊柱炎标准的制定：来自GRAPPA 2013年会的报告
J Rheumatol. 2014 Jun;41(6):1249-51. doi: 10.3899/jrheum.140182.
9
Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor.在一项口服磷酸二酯酶 4 抑制剂阿普米司特的 3 期随机、安慰剂对照试验中治疗银屑病关节炎。
Ann Rheum Dis. 2014 Jun;73(6):1020-6. doi: 10.1136/annrheumdis-2013-205056. Epub 2014 Mar 4.
10
Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials.乌司奴单抗，一种抗白细胞介素-12/23 p40 单克隆抗体，可抑制活动性银屑病关节炎患者的放射学进展：来自 3 期、多中心、随机、双盲、安慰剂对照 PSUMMIT-1 和 PSUMMIT-2 试验放射学数据的综合分析结果。
Ann Rheum Dis. 2014 Jun;73(6):1000-6. doi: 10.1136/annrheumdis-2013-204741. Epub 2014 Feb 19.
Zotero 插件